FDA appears to soften stance on hydroxychloroquine after Trump says he takes malaria drugThe FDA advised consumers against taking hydroxychloroquine for Covid-19 outside a hospital or formal clinical trial setting due to the risk of "serious heart rhythm problems."[Collection]

The FDA advised consumers against taking hydroxychloroquine for Covid-19 outside a hospital or formal clinical trial setting due to the risk of "serious heart rhythm problems."https://www.cnbc.com/2020/05/19/fda-appears-to-soften-stance-on-hydroxychloroquine-after-trump-says-he-takes-malaria-drug.html